Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIIP.L Regulatory News (IIP)

  • There is currently no data for IIP

Further Statement re COVID-19

27 Mar 2020 07:00

RNS Number : 7794H
Infrastructure India plc
27 March 2020
 

27 March 2020

 

 

Infrastructure India plc

("IIP", the "Company and together with its subsidiaries the "Group")

 

Further Statement re COVID-19

 

Infrastructure India plc, an AIM quoted infrastructure fund investing directly into assets in India, provides a further update following the announcement on Tuesday 24 March 2020 that the Government of India had ordered a complete national lockdown of non-essential activity for a minimum of 21 days in an effort to slow the spread of the COVID-19 coronavirus.

 

This action has immediate and significant consequences for all businesses in India and, in particular, the impact on the logistics sector and on IIP's largest asset, Distribution Logistics infrastructure Limited ("DLI"), is likely to prevail both during and well beyond the lockdown period.

 

For DLI, all construction activities at its terminals have now ceased and while some of its freight is essential, movements of cargoes are now negligible due to closures across the supply chain in India.

 

As announced by the Company on 17 March 2020, the effect of an earlier lockdown in China had already had a material impact on Indian container freight and container cycles and this is expected to be amplified by the lockdown in India and other global cargo and transportation hubs. It is currently impossible to predict when DLI, or the wider market, will recover to normal volumes.

 

In addition, IIP's wind and hydro energy assets are expected to begin to experience reduced demand with the operations of some industrial and commercial offtakers closed.

 

It is too early to quantify the effect of the lockdown for DLI and for the IIP portfolio companies, other than to note that the considerable impact it will have on all Indian businesses is likely to last for some time.

 

The wellbeing of IIP's stakeholders and the Indian communities in which IIP's portfolio companies operate is a key concern for the Company and IIP is supportive of the steps taken by Prime Minister Narendra Modi and the Indian Government to protect India and its citizens in what are unprecedented times.

 

The Board is working with DLI management and the management teams of IIP's other portfolio companies and continues to monitor the situation closely.

 

Further announcements will be made, as appropriate, in due course.

 

Enquiries:

 

Infrastructure India plc

Sonny Lulla 

 

 

www.iiplc.com

Via Novella

Cenkos Securities plc

Nominated Adviser & Joint Broker

Ben Jeynes / Katy Birkin

+44 (0) 20 7397 8900

Nplus1 Singer Advisory LLP

Joint Broker

James Maxwell - Corporate Finance

James Waterlow - Investment Fund Sales

 

+44 (0) 20 7496 3000

Novella

+44 (0) 20 3151 7008

Financial PR

Tim Robertson / Fergus Young

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEAKDKALXEEFA
Date   Source Headline
20th Apr 202212:55 pmRNSAsset Sale Update
4th Apr 20223:00 pmRNSExtension of Long Stop Date
14th Mar 20224:30 pmRNSExtension of Long Stop Date
28th Feb 20227:00 amRNSAsset Sale
13th Jan 20227:00 amRNSLiquidity and Financing Update
6th Jan 202210:00 amRNSHolding(s) in Company
31st Dec 202111:15 amRNSResult of AGM
24th Dec 20217:00 amRNSHalf-year Report
8th Dec 20217:00 amRNSFinal Results and Notice of AGM
26th Nov 202112:00 pmRNSNotice of Results
28th Oct 20217:00 amRNSNotice of Results
14th Sep 20217:00 amRNSNotice of Extension and Trading Update
13th Sep 20214:42 pmRNSSecond Price Monitoring Extn
13th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20212:02 pmRNSPrice Monitoring Extension
9th Aug 20217:00 amRNSTrading Statement
29th Jun 20217:00 amRNSLoan Restructuring
5th Mar 20219:06 amRNSSecond Price Monitoring Extn
5th Mar 20219:01 amRNSPrice Monitoring Extension
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:02 pmRNSPrice Monitoring Extension
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
7th Jan 202111:06 amRNSSecond Price Monitoring Extn
7th Jan 202111:03 amRNSPrice Monitoring Extension
7th Jan 20219:06 amRNSSecond Price Monitoring Extn
7th Jan 20219:02 amRNSPrice Monitoring Extension
5th Jan 20214:43 pmRNSSecond Price Monitoring Extn
5th Jan 20214:37 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSInterim Results
19th Nov 20202:30 pmRNSResult of AGM
18th Nov 20207:00 amRNSChange of Adviser
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
26th Oct 20204:27 pmRNSPosting of Annual Report & Notice of AGM
23rd Oct 20207:00 amRNSFinal Results
30th Sep 20202:06 pmRNSSecond Price Monitoring Extn
30th Sep 20202:01 pmRNSPrice Monitoring Extension
29th Sep 20202:14 pmRNSNotice of Results and Pre-Close Statement
14th Sep 20207:00 amRNSNotice of Results and Accounts Extension
17th Aug 20207:00 amRNSTrading Update
30th Apr 20202:07 pmRNSSecond Price Monitoring Extn
30th Apr 20202:01 pmRNSPrice Monitoring Extension
27th Apr 20203:54 pmRNSSMH Update
21st Apr 20208:41 amRNSDirectorate Change
27th Mar 20207:00 amRNSFurther Statement re COVID-19
24th Mar 20202:06 pmRNSSecond Price Monitoring Extn
24th Mar 20202:01 pmRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSTrading Update and Statement re COVID-19

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.